David J Mauro
CIK 1621172 · Chief Medical Officer · last filed 2024-11-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$750.9K
Companies
4
Total Filings
37
Lifetime Open-Market Net
-$5.86M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXRX | Chief Medical Officer | 225,429 | $3.15 | $710.1K | $0 | 5 | 2024-11-19 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Chief Medical Officer | — | $0.06 | — | $0 | 3 | 2023-01-26 |
| PRLD | Chief Medical Officer | 9,092 | $4.49 | $40.8K | -$5.61M | 11 | 2021-10-06 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Medical Officer | 166,271 | — | — | -$247.8K | 18 | 2016-01-04 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-09 | PRLD | Mixed | — | -$438.0K | EDGAR |
| 2021-07-22 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2021-07-08 | PRLD | Mixed | — | -$383.8K | EDGAR |
| 2021-06-09 | PRLD | Mixed | — | -$458.3K | EDGAR |
| 2021-05-10 | PRLD | Mixed | — | -$573.7K | EDGAR |
| 2021-04-29 | PRLD | Mixed | — | -$837.6K | EDGAR |
| 2021-04-21 | PRLD | Mixed | — | -$725.1K | EDGAR |
| 2021-04-15 | PRLD | Mixed | — | -$350.7K | EDGAR |
| 2021-04-09 | PRLD | Mixed | — | -$575.9K | EDGAR |
| 2016-01-04 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +154 | $1.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.